ID

4503

Descripción

ACNS1123 Eligibility Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Palabras clave

Versiones (2)
  1. 9/12/13 9/12/13 - Martin Dugas
  2. 2/6/15 2/6/15 -
Subido en

9 de diciembre de 2013

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

ACNS1123 Eligibility - 3377519v1.0

Inglés

No Instruction available.

1 formularios  
  1. StudyEvent: SE.0000
    1. No Instruction available.
Stratification
Descripción

Stratification

ACNS1123 Stratum
Descripción

ClinicalStudyACNS1123StratificationFactorsType

Tipo de datos

text

Study Treatment
Descripción

TreatmentAssignmentType

Tipo de datos

text

Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
Descripción

TreatmentBeginDate

Tipo de datos

date

Elig - Block 1
Descripción

Elig - Block 1

Is the patient enrolled on the ALTE07C1 study?
Descripción

OtherStudyEnrollmentInd-2

Tipo de datos

text

Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
Descripción

PatientAgeEligibilityDeterminationInd-2

Tipo de datos

text

Was definitive diagnostic surgery performed?
Descripción

FirstDiagnosisFromSurgicalProcedureIndicator

Tipo de datos

text

Date of definitive diagnostic surgery or clinical diagnosis:
Descripción

PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate

Tipo de datos

date

Was lumbar CSF cytology obtained?
Descripción

CerebrospinalFluidCellInd-3

Tipo de datos

text

Was it medically contraindicated? (If no,)
Descripción

CerebrospinalFluidDiagnosticProcedureCytologyContraindicatedInd-2

Tipo de datos

text

Was lumbar CSF cytology negative?
Descripción

LaboratoryProcedureLumbarPunctureCerebrospinalFluidNegativeFindingOutcomeInd-2

Tipo de datos

text

Elig - Block 2
Descripción

Elig - Block 2

Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
Descripción

GermCellTumorHistologicClassificationDiagnosisInd-2

Tipo de datos

text

Elig - Block 3
Descripción

Elig - Block 3

Does patient have newly diagnosed localized primary CNS NGGCT?
Descripción

NewPrimaryMalignantNeoplasmCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo de datos

text

Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
Descripción

PathologyFindingsIndicator

Tipo de datos

text

Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
Descripción

PatientProtocolRequirementEligibilityDeterminationInd-2

Tipo de datos

text

Elig - Block 4
Descripción

Elig - Block 4

Does patient have newly diagnosed localized primary CNS germinoma?
Descripción

NewChildhoodBrainGerminomaDiagnosisInd-2

Tipo de datos

text

Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
Descripción

PatientProtocolRequirementEligibilityDeterminationInd-2

Tipo de datos

text

Elig - Block 5
Descripción

Elig - Block 5

Peripheral absolute neutrophil count (ANC) (number/uL)
Descripción

LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • ul
ul
Platelet count (number/uL): (Transfusion Independent)
Descripción

LaboratoryProcedurePlateletResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • 1000/uL
1000/uL
Hemoglobin(g/dL) (May receive RBC transfusion)
Descripción

LaboratoryProcedureHemoglobinResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • g/dL
g/dL
Elig - Block 5
Descripción

Elig - Block 5

Creatinine clearance (mL/min/1.73m²):
Descripción

LaboratoryProcedureCreatinineClearanceOutcomeValue

Tipo de datos

double

Radioisotope GFR(mL/min/1.73 m²)
Descripción

LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue

Tipo de datos

double

Unidades de medida
  • mL/Min/1.73m2
mL/Min/1.73m2
Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
Descripción

LaboratoryProcedureCreatinineResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • mg/dL
mg/dL
Elig - Block 7
Descripción

Elig - Block 7

Total bilirubin (mg/dl), ULN
Descripción

LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue

Tipo de datos

double

Unidades de medida
  • mg/dL
mg/dL
Total bilirubin Value (mg/dl):
Descripción

LaboratoryProcedureTotalBilirubinResultValue

Tipo de datos

double

Unidades de medida
  • mg/dL
mg/dL
SGPT (ALT) or SGOT (AST) U/L, ULN:
Descripción

LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue

Tipo de datos

double

SGPT (ALT) or SGOT (AST), U/L
Descripción

LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue

Tipo de datos

double

Elig - Block 8
Descripción

Elig - Block 8

Does patient have seizure disorder?
Descripción

PatientSeizureDiseaseorDisorderInd-3

Tipo de datos

text

Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
Descripción

NeurologicalEvaluationSeizureSymptomInd-2

Tipo de datos

text

Is patient in status, coma or assisted ventilation at study entry?
Descripción

PatientMechanicalVentilationUseInd-2

Tipo de datos

text

Elig - Block 9
Descripción

Elig - Block 9

Does patient have mature teratoma with normal tumor markers?
Descripción

PatientCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo de datos

text

Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
Descripción

ExternalBrainVentricleCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo de datos

text

Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
Descripción

MetastaticDiseaseorDisorderMagneticResonanceImagingCerebrospinalFluidDiagnosisInd-2

Tipo de datos

text

Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
Descripción

SurgicalInterventionCorticosteroidAdministeredInd-2

Tipo de datos

text

Is patient post menarcheal?
Descripción

PediatricEndocrineMensesOnsetInd-2

Tipo de datos

text

Was a pregnancy test performed?
Descripción

PatientPregnancyTestIndicator

Tipo de datos

text

Is patient pregnant? (If yes above,)
Descripción

PatientPregnancyInd-2

Tipo de datos

text

Is patient nursing?
Descripción

PersonBreastFeedingExclusionCriteriaIndicator

Tipo de datos

text

Has patient agreed to stop breastfeeding? (If yes above,)
Descripción

BreastFeedingStopAgreementInd-4

Tipo de datos

text

Has patient agreed to use an effective contraceptive method for the duration of the study participation?
Descripción

ContraceptionAgreementInd

Tipo de datos

text

Elig - Block 10
Descripción

Elig - Block 10

Date Informed Consent Signed
Descripción

InformedConsentFormSignedDate

Tipo de datos

date

Have all institutional, FDA, and NCI requirements for human studies been met?
Descripción

StudyCompleteRequirementsInd-2

Tipo de datos

text

Comments
Descripción

ResearchCommentsText

Tipo de datos

text

Volver a la parte superior de la página

Similar models

No Instruction available.

1 formularios
  1. StudyEvent: SE.0000
    1. No Instruction available.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Stratification
CL.1
Code List
ACNS1123 Stratum
CL Item
Stratum 1 - Nggct (Stratum 1 - NGGCT)
CL Item
Stratum 2 - Germinoma (Stratum 2 - Germinoma)
Item
Study Treatment
text
CL.2
Code List
Study Treatment
CL Item
Treatment 1: A,b,a,b,a,b (Treatment 1 A B A B A B)
CL Item
Treatment 2: A,a,a,a (Treatment 2 A A A A)
TreatmentBeginDate
Item
Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
date
Item Group
Elig - Block 1
Item
Is the patient enrolled on the ALTE07C1 study?
text
CL.3
Code List
Is the patient enrolled on the ALTE07C1 study?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
text
CL.4
Code List
Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Was definitive diagnostic surgery performed?
text
CL.5
Code List
Was definitive diagnostic surgery performed?
CL Item
Yes (Yes)
CL Item
No (No)
PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate
Item
Date of definitive diagnostic surgery or clinical diagnosis:
date
Item
Was lumbar CSF cytology obtained?
text
CL.6
Code List
Was lumbar CSF cytology obtained?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Was it medically contraindicated? (If no,)
text
CL.7
Code List
Was it medically contraindicated? (If no,)
CL Item
Yes (Yes)
CL Item
No (No)
CL.8
Code List
Was lumbar CSF cytology negative?
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 2
Item
Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
text
CL.9
Code List
Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 3
Item
Does patient have newly diagnosed localized primary CNS NGGCT?
text
CL.10
Code List
Does patient have newly diagnosed localized primary CNS NGGCT?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
text
CL.11
Code List
Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
CL Item
Yes (YES)
CL Item
No (NO)
Item
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
text
CL.14
Code List
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have newly diagnosed localized primary CNS germinoma?
text
CL.13
Code List
Does patient have newly diagnosed localized primary CNS germinoma?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
text
CL.14
Code List
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
CL Item
Yes (Yes)
CL Item
No (No)
LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue
Item
Peripheral absolute neutrophil count (ANC) (number/uL)
double
LaboratoryProcedurePlateletResultSpecifiedValue
Item
Platelet count (number/uL): (Transfusion Independent)
double
LaboratoryProcedureHemoglobinResultSpecifiedValue
Item
Hemoglobin(g/dL) (May receive RBC transfusion)
double
LaboratoryProcedureCreatinineClearanceOutcomeValue
Item
Creatinine clearance (mL/min/1.73m²):
double
LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue
Item
Radioisotope GFR(mL/min/1.73 m²)
double
LaboratoryProcedureCreatinineResultSpecifiedValue
Item
Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
double
LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue
Item
Total bilirubin (mg/dl), ULN
double
LaboratoryProcedureTotalBilirubinResultValue
Item
Total bilirubin Value (mg/dl):
double
LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
Item
SGPT (ALT) or SGOT (AST) U/L, ULN:
double
LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue
Item
SGPT (ALT) or SGOT (AST), U/L
double
Item Group
Elig - Block 8
Item
Does patient have seizure disorder?
text
CL.15
Code List
Does patient have seizure disorder?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
text
CL.16
Code List
Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient in status, coma or assisted ventilation at study entry?
text
CL.17
Code List
Is patient in status, coma or assisted ventilation at study entry?
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 9
Item
Does patient have mature teratoma with normal tumor markers?
text
CL.18
Code List
Does patient have mature teratoma with normal tumor markers?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
text
CL.19
Code List
Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
text
CL.20
Code List
Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
text
CL.21
Code List
Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient post menarcheal?
text
CL.22
Code List
Is patient post menarcheal?
CL Item
Yes (yes)
CL Item
No (no)
Item
Was a pregnancy test performed?
text
CL.23
Code List
Was a pregnancy test performed?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient pregnant? (If yes above,)
text
CL.24
Code List
Is patient pregnant? (If yes above,)
CL Item
Yes (Yes)
CL Item
No (No)
CL.25
Code List
Is patient nursing?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Has patient agreed to stop breastfeeding? (If yes above,)
text
CL.26
Code List
Has patient agreed to stop breastfeeding? (If yes above,)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Has patient agreed to use an effective contraceptive method for the duration of the study participation?
text
CL.27
Code List
Has patient agreed to use an effective contraceptive method for the duration of the study participation?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/a, Patient Is Not Of Reproductive Potential (NA patient is not of reproductive potential)
Item Group
Elig - Block 10
InformedConsentFormSignedDate
Item
Date Informed Consent Signed
date
Item
Have all institutional, FDA, and NCI requirements for human studies been met?
text
CL.28
Code List
Have all institutional, FDA, and NCI requirements for human studies been met?
CL Item
Yes (Yes)
CL Item
No (No)
ResearchCommentsText
Item
Comments
text
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial